T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

September 30, 2007

Conditions
Type 1 Diabetes Mellitus
Interventions
PROCEDURE

T Cell Proliferation and Autoreactivity Assays

PROCEDURE

Cellular Immunoblot Assays

PROCEDURE

Tetramer Studies

PROCEDURE

Cytokine ELISPOT

Trial Locations (14)

10032

Naomi Berrie Diabetes Center, Columbia University, New York

15213

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

32608

University of Florida, Gainesville

33136

University of Miami School of Medicine, Miami

46202

Riley Hospital for Children, Indianapolis

55455

University of Minnesota, Minneapolis

75235

University of Texas Southwestern Medical Center at Dallas, Dallas

80010

Barbara Davis Center for Childhood Diabetes, Denver

90027

Childrens Hospital of Los Angeles, Los Angeles

98101

Benaroya Research Institute at Virginia Mason, Seattle

94143-0136

University of California, San Francisco, San Francisco

94305-5208

Stanford University Medical Center, Stanford

02215

Joslin Diabetes Center, Boston

BS10 5NB

University of Bristol, Bristol

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00212329 - T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter